We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities in Medical


PlaqueTec Medical EIS
Cardiovascular Disease is the leading cause of death in the UK, PlaqueTec have developed a Liquid Biopsy System, which allows cardiologists to gain further information from a patient's coronary artery and provide more effective treatment to those affected by the disease.
investment: £1,493,593 target: £2,100,058 pre-money valuation: £12,003,757
status: Active
More Information
71%
CELLMED Medical EIS
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.    
investment: £520,294 target: £500,000 pre-money valuation: £2,400,232
status: Stretch
More Information
104%
Bivictrix Therapeutics Limited Medical EIS SEIS
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
investment: £451,506 target: £430,000 pre-money valuation: £4,347,778
status: Extended
More Information
105%
Pertinax Pharma Medical EIS
Infections can be reduced and patient quality of life can be improved by using antimicrobial wound care materials developed by Pertinax. In vitro studies have already been performed using the company's development across multiple applications.
investment: £616,916 target: £699,997 pre-money valuation: £1,799,992
status: Active
More Information
88%
Dentinal Tubules Medical EIS
Providing dental professionals with an online Personal Development Plan for their Continuing Professional Development. Dentinal Tubules currently has more than 2,100 individuals registered to use the service and over 2,700 dental practice professionals that are paying for a subscription. Dentinal Tubules hosts more than 1,500 educational and certified videos to help with a professional's CPD, in addition they also offer live courses, a livestream and an annual congress. Investments will be used to enhance, develop and bring the technology in-house.
investment: £132,430 target: £250,000 pre-money valuation: £2,056,151
status: Active 7 days
to go
More Information
53%
Sutrue Medical EIS
The world's first automated suturing tools for safe closure of standard and endoscopic wounds. Sutrue have already patented their devices and use industry-standard needles to offer clinical quality with improved speed and accuracy at the touch of a button. Needles are held in disposable cartridges as a safety feature to prevent injury when piercing skin with contaminated needles. This protects staff both during and after surgery for those working in medical and veterinary environments. Sutrue is raising finance for the production process of their equipment, as well as applying for CE regulation via medical evaluations to receive approval to deploy their products in human and animal surgeries.
investment: £0 target: £750,000
status: Funded 78 days
to go
More Information
0%
Premium Arcis Biotechnology Medical EIS
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
investment: £1,146,318 target: £999,999 pre-money valuation: £19,202,001
status: Expired
More Information
115%
Premium OLBERON MEDICAL Medical EIS
Olberon is a UK based medical device innovations company seeking to raise funds for manufacturing and the sale of Vacuderm which is a device designed to assist with childrens cannulation procedure. Olberon Ltd has already got a strong portfolio of patented medical innovations and two medical devices which are market ready.
investment: £5,634 target: £100,000 pre-money valuation: £1,399,250
status: Expired
More Information
6%
Premium DC Surgical Supplies Limited Medical EIS SEIS
Reducing the cost of orthopaedic equipment by using compression screws and titanium maxiangle locking plates. DC Surgical Supplies have acquired an exclusive license with Palmer & Baker with the aim of helping the NHS cut the cost of purchasing regular-use equipment by as much as 35%. Their product is CE Certified and has been featured in The Telegraph.
investment: £99,000 target: £325,000 pre-money valuation: £487,500
status: Expired
More Information
30%
Premium Aseptium Medical EIS
During their stay in hospital, around 7-10% of patients attract unexpected infections. In some cases, this is caused by unclean complex surgical tools. Aspetium have developed ultrasonic washers (dubbed "uSonic") to thoroughly decontaminate expensive surgical instruments, which can be safely reused to potentially prevent easily avoidable infections.
investment: £150,903 target: £90,009 pre-money valuation: £2,343,452
status: Expired
More Information
168%
ENXRAY Medical
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.
investment: £376,230 target: £400,000 pre-money valuation: £4,924,046
status: Expired
More Information
94%
Cell Guidance Systems Medical EIS
Cell Guidance Systems is developing a technology called PODS (Polyhedrin Delivery System) PODS allow them to deliver therapeutic proteins accurately and over long periods of time. PODS enable proteins to treat diseases, such as Parkinson’s disease and osteoarthritis.
investment: £847,050 target: £500,000 pre-money valuation: £9,250,000
status: Expired
More Information
169%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph